Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
Identifying pathways that cause pathological cardiac hypertrophy holds great therapeutic potential. Here the authors discover one such pathway and show that SIKE, an inhibitor of interferon signalling, prevents pathological but not physiological cardiac hypertrophy by interacting with TBK1 and modul...
Main Authors: | Ke-Qiong Deng, Aibing Wang, Yan-Xiao Ji, Xiao-Jing Zhang, Jing Fang, Yan Zhang, Peng Zhang, Xi Jiang, Lu Gao, Xue-Yong Zhu, Yichao Zhao, Lingchen Gao, Qinglin Yang, Xue-Hai Zhu, Xiang Wei, Jun Pu, Hongliang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms11432 |
Similar Items
-
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
by: Yan-Xiao Ji, et al.
Published: (2016-06-01) -
STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress
by: Yan Zhang, et al.
Published: (2020-05-01) -
Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway
by: Hai-han Liao, et al.
Published: (2019-01-01) -
Using structural analysis to investigate the function of Suppressor of IKK-epsilon (SIKE)
by: McKinley, Sean W
Published: (2014) -
Speckle Tracking Based Strain Analysis Is Sensitive for Early Detection of Pathological Cardiac Hypertrophy.
by: Xiangbo An, et al.
Published: (2016-01-01)